Approval · Notice of Compliance 29321 · 2022
TIMOPTIC: Notice of Compliance 29321
Issued October 25, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29321
- Date
- October 25, 2022
- Company
- Elvium Life SciencesToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Conversion of the Product Monograph to the 2020 format and to update the labels to align with plain language labelling regulations.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TIMOPTIC | Not yet assigned | — |
Medicinal ingredients
- TIMOLOL MALEATE 0.5 PER